Poultry Vaccines Market to Grow with a CAGR of 6.64% through 2030
Rising global poultry consumption, and the imperative to prevent disease
outbreaks is expected to drive the Global Poultry Vaccines Market growth in the
forecast period, 2024-2028.
According to TechSci Research report, “Poultry Vaccines Market – Global
Industry Size, Share, Trends, Competition Forecast & Opportunities,
2030”, the Global Poultry Vaccines Market stood at USD 1.89 Billion in 2024 and is anticipated to grow with a CAGR of 6.64% in the forecast period through 2030. This can be attributed to increasing awareness of animal health. There
is a growing awareness of the importance of animal health and welfare among
consumers, farmers, and policymakers. This heightened awareness has led to
increased investment in animal healthcare, including vaccination programs.
Poultry farmers are more inclined to adopt preventive measures like vaccination
to protect their flocks, thereby driving the demand for poultry vaccines. Moreover,
biotechnology and genetic advancements are enabling the development of
genetically resistant poultry breeds. These breeds have enhanced natural
immunity to specific diseases, reducing the reliance on vaccines. As these
technologies progress, they may reshape the landscape of disease prevention in
the poultry industry.
The market is being propelled by various factors, including intensified
research and development efforts, an escalating occurrence of poultry diseases,
the imperative to secure food supplies, and heightened awareness and
initiatives aimed at mitigating antimicrobial resistance. In 2019, HIPRA expanded its portfolio of coccidiosis vaccines by
introducing EVANT, an attenuated vaccine designed for broilers. However, the
poultry industry suffered adverse effects from the COVID-19 pandemic,
experiencing reduced demand, sluggish sales, surplus inventory, and a decline
in the prices of poultry meat and eggs. This impact was particularly severe in
countries like India, which have substantial poultry populations. Although egg,
dairy, and meat production were considered essential services, lockdowns and
movement restrictions disrupted the supply chain. These challenges, coupled
with concerns about other avian diseases such as Bird flu in India, exacerbated
the pandemic's negative repercussions.
Nevertheless, the COVID-19 pandemic has created opportunities for
vaccine manufacturers to gain market share. This is due to the growing
awareness of animal diseases, the demand for safe food sources and products,
and concerns about zoonotic diseases. Venkys India, for example, is a prominent
player in the market, engaged in various aspects of the poultry industry,
including SPF egg production, broiler and layer breeding, chicken and egg
processing, poultry feed and equipment, vaccine manufacturing, and more. In
2019, the company's diverse poultry product portfolio, including vaccines,
accounted for 45% of its revenue.
The increasing poultry population, coupled with the rising prevalence of
avian diseases, is expected to fuel the demand for poultry vaccines. The
consumption of infected poultry meat poses a risk to human health, making it
crucial to vaccinate birds before use. Poultry farms face significant
challenges in preventing the rapid spread of diseases and have limited
treatment options, making vaccination a necessity. In 2019, the United States
had 19.72 million livestock units of chickens, while Brazil had 14.6 million
livestock units. These substantial poultry populations indicate a significant
number of birds susceptible to avian diseases, which can be effectively
prevented through timely vaccinations.
According to the OIE-WAHIS database, there were a total of 22 new
outbreaks in birds worldwide. This number surged to 836 new outbreaks in 2020,
with estimated cases reaching 2.79 million. The increasing incidence of disease
outbreaks among avian populations is therefore a significant driver for the
market. Recent disease notifications include reports of low pathogenic avian
influenza in poultry in Italy and highly pathogenic avian influenza in Russia
in October 2021.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Poultry Vaccines Market.”
The Global Poultry Vaccines Market is segmented into Application, Product, Disease Type, Regional Distribution, and Company.
Based on Product, the attenuated live vaccine category is projected to exhibit the fastest growth in the poultry vaccines market. This growth is primarily driven by the superior efficacy of live vaccines in providing long-term immunity and rapid onset of action compared to inactivated or subunit vaccines. Attenuated live vaccines stimulate a stronger immune response by mimicking natural infection, making them especially effective against various avian diseases such as Newcastle disease, infectious bronchitis, and avian influenza. Their increased adoption in commercial poultry farming—aimed at reducing mortality rates and improving overall flock health—is further boosting demand. Additionally, ongoing advancements in vaccine delivery methods, such as spray and drinking water administration, are enhancing their usability and effectiveness, contributing to their accelerated market growth.
Based on region, Asia Pacific is expected to demonstrate the fastest growth in the poultry vaccines market during the forecast period. This rapid expansion can be attributed to several factors, including the rising demand for poultry products due to increasing population, urbanization, and changing dietary preferences across countries like China, India, and Southeast Asian nations. Moreover, the region has witnessed a surge in poultry farming activities, both small-scale and commercial, necessitating the adoption of effective vaccination programs to prevent disease outbreaks and ensure food security. Government initiatives to improve animal health, coupled with growing awareness among poultry farmers about the benefits of immunization, are further driving market growth. Additionally, frequent outbreaks of avian diseases in the region have prompted stronger biosecurity measures and vaccination efforts, fueling demand for advanced poultry vaccines. The presence of both global and local vaccine manufacturers investing in R&D and expanding their operations across Asia Pacific is also contributing to the region's market momentum.
Major companies operating in Global Poultry Vaccines Market
are:
- Boehringer Ingelheim
GmbH
- Zoetis Inc
- Elanco LLC
- Intervet Inc
- Hester Biosciences Ltd
- Vaxxinova GmbH
- Venky's India Ltd
- Laboratorios Calier SA
- KM Biologics Co Ltd
- Phibro Animal Health
Corporation
Download Free Sample Report
Customers can also request for 10% free customization on this report
“The global poultry vaccines market is on the cusp of significant
transformations driven by emerging trends. Precision vaccination,
immune-boosting adjuvants, DNA vaccines, innovative vaccine delivery systems,
regional-specific vaccines, data-driven decision-making, ethical and
sustainable practices, and biotechnology solutions are among the key trends
shaping the industry's future. These trends reflect a commitment to improving
poultry health, production efficiency, and disease prevention while meeting the
ethical and sustainability demands of the modern world. As the industry
continues to evolve, stakeholders in the poultry vaccines market should remain
agile and adaptable to leverage these trends for the benefit of poultry health
and global food security,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.
“Poultry Vaccines Market By Application (Broiler, Layer, Breeder), By Product (Attenuated Live
Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant
Vaccines), By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases,
Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral
Enteritis, Inclusion Body Hepatitis, Salmonella, Others), By
Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Poultry Vaccines
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Poultry Vaccines
Market.
Contact
TechSci Research LLC
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com